Evidence map›Paper›PMID 35815182›Full record

ArticleCritical care explorations2022

Chemokines in ICU Delirium: An Exploratory Study.

Ryan J Smith, Alejandro A Rabinstein, Rodrigo Cartin-Ceba, Vijay P Singh, Christian Lachner, Biswajit Khatua, Shubham Trivedi, Ognjen Gajic

Open access · goldAbstract read
In one paragraph

Article in Critical care explorations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ryan J SmithMayo Clinic School of Graduate Medical Education, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Alejandro A RabinsteinDepartment of Neurology, Mayo Clinic, Rochester, MN.
Rodrigo Cartin-CebaDepartment of Critical Care Medicine, Mayo Clinic, Phoenix, AZ.
Vijay P SinghDivision of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ.
Christian LachnerDivision of Psychiatry, Mayo Clinic, Jacksonville, FL.
Biswajit KhatuaDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Shubham TrivediDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Ognjen GajicDepartment of Critical Care Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic in Arizona · USWinnMed · USMayo Clinic Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe pathophysiology of delirium is complex and incompletely understood. Inflammation is hypothesized to be integral to its development due to effects on blood brain barrier integrity, facilitation of leukocyte extravasation into brain parenchyma, and propagation of neuroinflammation. Septic shock is the prototypical condition associated with ICU delirium; however, the relative contribution of resultant hypotension and systemic inflammation to the development of delirium is unknown.

designThis was a prospective exploratory study.

settingA multidisciplinary ICU at an academic medical center in Phoenix, AZ. PATIENTS: Critically ill patients older than or equal to 18 years old admitted to the ICU.

interventionsNone. MEASUREMENTS AND MAIN

resultsScreening for delirium was performed using the Confusion Assessment Method for the ICU tool. The levels of C-C motif ligand 2 (CCL2), C-C motif ligand 3, C-X-C motif chemokine ligand 1, C-X-C motif chemokine ligand 10, and interleukin-8 were measured in serum samples obtained within 12 hours of ICU admission. Univariate and multivariate analyses were performed to assess the association of delirium with patient data pertaining to hospital course, laboratory values, vital signs, medication administration, and levels of the aforementioned chemokines. Forty-one of 119 patients (34.5%) in the study cohort developed ICU delirium. Each chemokine studied was associated with delirium on univariate analyses; however, CCL2 was the only chemokine found to be independently associated with the development of delirium on multivariable analysis. The association of increased CCL2 levels with delirium remained robust in various models controlling for age, presence of shock, Sequential Organ Failure Assessment score, Acute Physiology and Chronic Health Evaluation IV score, mean arterial pressure at presentation, lowest mean arterial pressure, and total opioid, midazolam, propofol, and dexmedetomidine exposure.

conclusionsThe demonstrated relationship between CCL2 and delirium suggests this chemokine may play a role in the development of delirium and warrants further investigation.

Indexed as

chemokinecytokinedeliriuminflammationintensive care unit

Identifiers

PMID35815182
PMCPMC9259165
OpenAlexW4284713171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.